Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ekaterina V. Zaikina"'
Autor:
O. V. Pandova, E.Yu. Zlatnik, S. Yu. Filippova, L. Z. Kurbanova, Yu. A. Sayapin, A. V. Volkova, A. N. Shevchenko, E. A. Gusakov, D. V. Khodakova, E.A. Lukbanova, Ekaterina V. Zaikina, Dmitry O. Kaymakchi, Ju. N. Lazutin
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 49, Iss 0 (2020)
Rationale: Chemotherapy is one of the lung cancer treatment methods. The search for new substances with antitumor effect against malignant lung neoplasms is relevant because of low efficacy and side effects of cytotoxic agents. A promising substance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ee7a2abfc9f4a7b7622dc9c1549544
https://doi.org/10.18786/2072-0505-2021-49-021
https://doi.org/10.18786/2072-0505-2021-49-021
Autor:
Nikita Vasilchenko, Aleksei Maksimov, Sergei Chapek, Vyatcheslav Volovik, Anastasia Volkova, Dmitry Potemkin, E.A. Lukbanova, Nikolai Karnaukhov, Ekaterina V. Zaikina, Mariya Mindar, Anna S. Goncharova, T.P. Protasova, Dariya Khodakova
Publikováno v:
Problems in oncology. 67:127-133
Aim of the study – the development of a method for obtaining a tumor xenograft model by a subcutaneous transplantation of a porous metal scaffold populated with cultured human lung carcinoma cells. Material and methods. The study included 14 athymi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2e2f6c2b6e5e255a566089830c652de
https://doi.org/10.37469/0507-3758-2021-67-1-127-133
https://doi.org/10.37469/0507-3758-2021-67-1-127-133
Autor:
Nikolay S. Karnaukhov, D. V. Khodakova, A.Yu. Maksimov, M. V. Mindar, I. M. Akulshina, E.A. Lukbanova, A. V. Volkova, Vladimir Trifanov, Sergei Kit, Ekaterina V. Zaikina, T.P. Protasova, Anna S. Goncharova, S. Yu. Tkachev
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 2, Pp 117-124 (2020)
Background: Orthotopic patient-derived xenografts (PDX) in immunodeficient mice are recognized as the most adequate neoplastic model due to their ability to maintain primary tumor properties after implantation. They can be used to study anti-neoplast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc6e171c5ceebf3bcbb567863c56d295
https://www.almclinmed.ru/jour/article/view/1323
https://www.almclinmed.ru/jour/article/view/1323
Autor:
L. Z. Kurbanova, Nataliya Shevchenko, Ekaterina V. Verenikina, Ekaterina Fedorovna Komarova, Elena V. Filatova, Irina A. Khomutenko, Anna S. Goncharova, Ekaterina A. Lukbanova, D. V. Khodakova, A. V. Galina, Maria V. Mindar, Ekaterina V. Zaikina, Elizaveta Komarova
Publikováno v:
Journal of Clinical Oncology. 40:e21562-e21562
e21562 Background: Study of the influence of a pharmacological substance dihydrobromide-2-(3,4-dihydroxyphenyl)-9-diethylaminoethylimidazo-[1,2-a] benzimidazole on the tumor growth on a model of experimental transplantable B16 melanoma in mice. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4b959e8ff9068870deb6fffc706becd
https://doi.org/10.1200/jco.2022.40.16_suppl.e21562
https://doi.org/10.1200/jco.2022.40.16_suppl.e21562
Autor:
Georgiy Yu. Egorov, Anna S. Goncharova, D. V. Khodakova, L. Z. Kurbanova, Maria V. Mindar, Ekaterina V. Zaikina, Ekaterina Fedorovna Komarova, Evgeniy N. Kolesnikov, Aleksey Yu. Maksimov, Tanzila B. Katsieva, Roman E. Myagkov, Mikhail A. Averkin, Aleksandr V. Snezhko, Umar M. Gaziev, Nadezhda V. Nikolaeva
Publikováno v:
Journal of Clinical Oncology. 40:e15612-e15612
e15612 Background: The purpose of this study was to create a patient-derived xenograft model of human colorectal cancer and to determine its histological and molecular characteristics, including the status of the KRAS, NRAS, BRAF genes and the presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51e145e5279ba8b708db88ff629774b5
https://doi.org/10.1200/jco.2022.40.16_suppl.e15612
https://doi.org/10.1200/jco.2022.40.16_suppl.e15612
Autor:
Dmitry Aleksandrovich Shvyrev, E.A. Lukbanova, Ekaterina V. Zaikina, Evgeniy A. Gusakov, D. V. Khodakova, Yuriy A. Sayapin, Yuriy N. Lazutin, Irina A. Khomutenko, M. V. Mindar, Alexey N. Shevchenko, Anna S. Goncharova, Elena V. Filatova, A. V. Volkova
Publikováno v:
Journal of Clinical Oncology. 39:e15008-e15008
e15008 Background: Lung cancer is the most common cancer worldwide. The efficacy of chemotherapy for this tumor does not exceed 40%. Moreover, all cytotoxic agents cause many side effects. The search for new substances with an antitumor effect seems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc452404b63f7055a294c6565b385745
https://doi.org/10.1200/jco.2021.39.15_suppl.e15008
https://doi.org/10.1200/jco.2021.39.15_suppl.e15008
Autor:
M. V. Mindar, L. Z. Kurbanova, A. V. Volkova, Roman E. Myagkov, E.A. Lukbanova, Tanzila B. Katsieva, Ekaterina V. Zaikina, Aleksandr E. Anisimov, Evgeniy N. Kolesnikov, Mikhail A Kozhushko, Sergey V. Sanamyants, D. V. Khodakova, Anna S. Goncharova
Publikováno v:
Journal of Clinical Oncology. 39:e15033-e15033
e15033 Background: Cardioesophageal cancer is a common tumor affecting the cardiac stomach and lower esophagus. Tumor heterogeneity is important, since it can cause the ineffectiveness of chemotherapy and radiotherapy due to individual characteristic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7af62373fe6a497452a741af55b54b99
https://doi.org/10.1200/jco.2021.39.15_suppl.e15033
https://doi.org/10.1200/jco.2021.39.15_suppl.e15033
Autor:
Sergey V. Sanamyants, M. V. Mindar, A. V. Volkova, Roman E. Myagkov, D. V. Khodakova, L. Z. Kurbanova, Aleksandr E. Anisimov, Anna S. Goncharova, Evgeniy N. Kolesnikov, E.A. Lukbanova, Ekaterina V. Zaikina, Mikhail A Kozhushko, Tanzila B. Katsieva
Publikováno v:
Journal of Clinical Oncology. 39:e15034-e15034
e15034 Background: Cardioesophageal cancer is one of the most common tumors affecting the mucosa of the cardiac stomach and distal esophagus. Despite the variety of treatment strategies and chemotherapy agents, the prognosis for the patients remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77c0b445a024e702db8d74e4f761bd29
https://doi.org/10.1200/jco.2021.39.15_suppl.e15034
https://doi.org/10.1200/jco.2021.39.15_suppl.e15034
Autor:
A. V. Volkova, Ekaterina V. Zaikina, Ekaterina V. Verenikina, L. Z. Kurbanova, M. V. Mindar, Anna P. Menshenina, Anna S. Goncharova, E.A. Lukbanova, Meri L. Adamyan, D. V. Khodakova, Anna Yu. Ardzha
Publikováno v:
Journal of Clinical Oncology. 39:e15010-e15010
e15010 Background: Ovarian cancer (OC) is the fourth most common cancer in women aged 40-54 years. Despite advances in cancer research, no existing methods provide effective early diagnosis and treatment of OC, so the search for new medications is an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::613928af1f20baf322127eba1afc3a45
https://doi.org/10.1200/jco.2021.39.15_suppl.e15010
https://doi.org/10.1200/jco.2021.39.15_suppl.e15010
Autor:
A. V. Volkova, Ekaterina V. Zaikina, E.A. Lukbanova, Anna S. Goncharova, L. Z. Kurbanova, Rostorguev Eduard Evgenievich, M. V. Mindar, D. V. Khodakova, Vladislav E. Khatyushin, Sergey E. Kavitskiy
Publikováno v:
Journal of Clinical Oncology. 39:e15011-e15011
e15011 Background: Poor clinical effects of standard treatment for glioblastoma determine the need for the development of new therapeutic strategies. Aberrant functioning of the proteasome system, as well as activation of the HIF-1α signaling pathwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::793f5a785c3439286b59378032a7acab
https://doi.org/10.1200/jco.2021.39.15_suppl.e15011
https://doi.org/10.1200/jco.2021.39.15_suppl.e15011